Deferasirox 69097-0560-53
- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Granule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 23, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215026
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 180 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
69097-0560-53Selected30 PACKET in 1 CARTON (69097-560-53) / 1 GRANULE in 1 PACKET